Latest Quarterly Reporting News

DroneShield Limited has reported a record-breaking second quarter with revenues surging 480% year-on-year, underpinned by a robust $176 million in committed sales and a $2.3 billion pipeline. The company is aggressively expanding manufacturing and investing in next-generation counter-drone technologies to meet soaring global demand.

Metals Australia reports a 595% surge in graphitic carbon intervals at its Lac Carheil project, advances critical infrastructure funding applications, and initiates copper-gold drilling at Warrego East.

Legacy Iron Ore Limited reported solid progress in its June 2025 quarter, with ongoing gold production at South Laverton and key development milestones at the Mount Bevan magnetite project.

Triangle Energy’s June quarter report reveals a strategic pivot as key JV partners exit, the Cliff Head assets transition to carbon capture, and promising exploration prospects remain in focus.

Oliver’s Real Food Limited reported a 70% increase in EBIT for the June 2025 quarter, driven by cost-cutting and operational improvements, despite a nearly 6% decline in revenue due to store closures and external factors.

Centuria Capital No. 2 Fund confirms full compliance with note terms and stable loan positions in its Q4 FY25 report, reassuring investors amid a steady operational quarter.

Lion Energy Limited reported a net cash outflow in Q2 2025 but maintains a solid cash position of AUD 2.13 million alongside a convertible note facility, signaling cautious optimism for its exploration activities.

Gullewa Limited reports significant progress in its mining and property ventures, including a major drilling campaign and lot sales, setting the stage for an updated resource estimate.

Brazilian Rare Earths Limited (BRE) confirms Sulista West as an ultra high-grade rare earth project with exceptional drill results and reports metallurgical breakthroughs at Monte Alto, underpinning its integrated supply chain ambitions.

Vitasora Health Limited reported a remarkable 226% increase in patient programs and secured an $11 million capital raise, positioning the company for accelerated growth and a path to cash flow breakeven in late 2026.

Osteopore Limited reports a three-fold increase in craniofacial implant sales within a year of signing an exclusive distribution deal with Zimmer Biomet, signaling strong early traction across key global markets.

Adveritas Limited reports a robust 62% increase in annualised recurring revenue to $10.47 million and a record doubling of full-year cash receipts, backed by a strategic $8.5 million institutional placement to accelerate growth in the US and new verticals.